Financials
- Market Capitalization 45.58 M
- Employee 18
- Founded 2020
- CEO N/A
- Website www.tevogen.com
- Headquarter Delaware, United States
- FIGI BBG013395405
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.91
Relación precio/flujo de caja
-67.95
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4302 | GRCE Grace Therapeutics, Inc. - Common Stock | 2.10 USD | -1.41% | -4.55% | -1.41% | -47.24% | 44.18 M USD | ||
| 4306 | MGX Metagenomi Therapeutics, Inc. - Common Stock | 1.17 USD | -0.85% | -3.31% | -1.68% | -18.75% | 44.20 M USD | ||
| 4313 | TCRX TScan Therapeutics, Inc. - Common Stock | 0.67 USD | -8.22% | -15.19% | -11.84% | -62.78% | 42.55 M USD | ||
| 4315 | KPTI Karyopharm Therapeutics Inc. - Common Stock | 1.86 USD | -9.71% | -3.13% | -4.12% | -80.71% | 42.19 M USD |